NeuroOne Medical Technologies Corp. is a medical technology company, which engages in diagnostics, ablations, and deep brain stimulation technology for brain-related conditions. Its products include Evo Cortical, Evo sEEG, and OneRF. The company was founded by Mark Christianson on August 20, 2009 and is headquartered in Eden Prairie, MN.
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. NeuroOne Medical Technologies Corp market cap is $5.94M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. NeuroOne Medical Technologies Corp 52 week high is $6.12 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. NeuroOne Medical Technologies Corp 52 week low is $0.6101 as of November 22, 2026.
NeuroOne Medical Technologies Corp stock price today is $0.6521.
NeuroOne Medical Technologies Corp stock price yesterday was $0.6749.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. NeuroOne Medical Technologies Corp's P/E ratio is -0.71.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. NeuroOne Medical Technologies Corp P/B ratio is 1.5064.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. NeuroOne Medical Technologies Corp 50-day moving average is $1.03.
NeuroOne Medical Technologies Corp has 18 employees.